---
title: "Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing To Advance Spectris™ In Alzheimer’S Disease"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277940505.md"
datetime: "2026-03-05T13:04:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277940505.md)
  - [en](https://longbridge.com/en/news/277940505.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277940505.md)
---

# Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing To Advance Spectris™ In Alzheimer’S Disease

March 5 (Reuters) - \* COGNITO THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $105 MILLION SERIES C FINANCING TO ADVANCE SPECTRIS™ IN ALZHEIMER’S DISEASE Source text: Further company coverage: \[ \]

### Related Stocks

- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIS.US](https://longbridge.com/en/quote/BIS.US.md)

## Related News & Research

- [Goldman Sachs Sticks to Their Buy Rating for Aclaris Therapeutics (ACRS)](https://longbridge.com/en/news/283014601.md)
- [BUZZ-Cancer biotech Adlai Nortye jumps after $150 mln equity financing](https://longbridge.com/en/news/282996483.md)
- [08:00 ETSapience Therapeutics Announces Participation in the 25th Annual Needham Virtual Healthcare Conference](https://longbridge.com/en/news/282539752.md)
- [Artiva Biotherapeutics Spotlights RA as Lead NK Cell Program, Eyes H1 Efficacy Data Catalyst at Needham](https://longbridge.com/en/news/282904330.md)
- [Janux Therapeutics Lacking Near-Term Catalysts, UBS Says](https://longbridge.com/en/news/282877328.md)